
ONC News
BeOne Medicines Ltd.
$399.70
-$3.90(-0.97%)
58
Overall
40
Value
66
Tech
68
Quality
Market Cap
$46.10B
Volume
212.08K
52W Range
$253.95 - $424.73
Target Price
$446.08
ONC news: the latest BeOne Medicines Ltd. headlines, press releases and market updates, newest first.
Latest ONC News
- J.P. Morgan Keeps Their Buy Rating on BeOne Medicines (ONC)TipRanks Auto-Generated Intelligence Newsdesk · Nov 19, 2026
- Bernstein Sticks to Their Buy Rating for Moncler S.p.A. (0QII)TipRanks Auto-Generated Intelligence Newsdesk · Nov 19, 2026
- Oncosem Awarded TRY 21,200,820.50 Needle-Free Valve TenderTipRanks Turkey Auto-Generated Newsdesk · Nov 19, 2026
- Oncosem Submits 2026 Third-Quarter Provisional Tax Income StatementTipRanks Turkey Auto-Generated Newsdesk · Nov 17, 2026
- Oncolytics Biotech Faces Nasdaq Delisting Risk as Shares Trade Below $1 ThresholdTipRanks Auto-Generated Newsdesk · Nov 15, 2026
- Oncosem Reports Nine-Month 2026 Revenue Growth and Profitability GainsTipRanks Turkey Auto-Generated Newsdesk · Nov 12, 2026
- CLSA Keeps Their Buy Rating on BeOne Medicines Ltd (6160)TipRanks Auto-Generated Intelligence Newsdesk · Nov 10, 2026
- BeOne Medicines Ltd (6160) Gets a Buy from CICCTipRanks Auto-Generated Intelligence Newsdesk · Nov 7, 2026
- UBS Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)TipRanks Auto-Generated Intelligence Newsdesk · Nov 7, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viridian Therapeutics (VRDN), Insulet (PODD) and BeOne Medicines (ONC)TipRanks Newsroom · Nov 6, 2026
- ONICO Repays PLN 2.4 Million Arrangement InstallmentTipRanks Poland Auto-Generated Newsdesk · Nov 6, 2026
- Onconetix Amends Realbotix Share Exchange Agreement, Extends End DateTipRanks Auto-Generated Newsdesk · Nov 6, 2026
- Oncopeptides Reports Strong Pepaxti Growth and Glioblastoma BreakthroughTipRanks Sweden Auto-Generated Newsdesk · Nov 5, 2026
- H.C. Wainwright Sticks to Their Buy Rating for Oncolytics Biotech (ONCY)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Oncolytics Biotech Reports Pelareorep Immune Activation in Anal CancerTipRanks Auto-Generated Newsdesk · Nov 4, 2026
- Stock Splits on Deck This Week (November 2 to November 6) – Stay InvestedBen Yoffe · Nov 1, 2026
- Oncoclínicas Secures Creditor Quorum for R$ 5.7 Billion Out-of-Court RestructuringTipRanks Brazil Auto-Generated Newsdesk · Oct 30, 2026
- BeOne Medicines’ Lung Cancer Combo Trial Nears Key Data MilestoneTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 30, 2026
- Borsa Istanbul Triggers Circuit Breaker in Oncosem SharesTipRanks Turkey Auto-Generated Newsdesk · Oct 30, 2026
- Oncoclínicas Updates Out-of-Court Restructuring Plan as Creditor Support BuildsTipRanks Brazil Auto-Generated Newsdesk · Oct 29, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ONC | $399.70 | -1.0% | 212.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |